Wallenstam AB (publ) (WALL-B)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 36.60 |
|---|---|
| 52-week range | 34.00 – 45.69 |
| Return, 1 month / 3 months | −2.8% / −9.9% |
| Return, 1 year / 3 years | −18.0% / −1.4% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 21.6% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 23.54M SEK |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wallenstam AB is a Swedish property company based in Gothenburg. It owns and manages residential rental properties, chiefly apartments in and around the larger Swedish cities, and it also develops and constructs new homes and commercial premises for its own portfolio. Its customers are mainly tenants of its residential and commercial properties, together with the municipalities and businesses that take space in its buildings. The company works across property management, project development and construction within Sweden.
Wallenstam AB (publ) trades under the code WALL-B on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wallenstam AB (publ) (WALL-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 36.60 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 277 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.0% and over the last three months it fell 9.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.2% | ||
| From 52-week high | -19.4% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.9% | ||
| 6-month return | -9.3% | ||
| 12-month return, skipping the last month | -15.7% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 23.54M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +6.9% |
|---|---|
| 1 month | −2.8% |
| 3 months | −9.9% |
| 6 months | −9.3% |
| 1 year | −18.0% |
| 3 years | −1.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 38.46 / 40.30 |
|---|---|
| Golden / death cross (60 days) | Death, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Oct 2026 | SEK 0.2500 |
| 29 Apr 2026 | SEK 0.3000 |
| 31 Oct 2025 | SEK 0.2500 |
| 30 Apr 2025 | SEK 0.2500 |
| 28 Oct 2024 | SEK 0.2500 |
| 26 Apr 2024 | SEK 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.